OR WAIT null SECS
December 13, 2025
Article
The FDA has approved etripamil nasal spray for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia to sinus rhythm.
December 04, 2025
Catch up with major FDA decisions, critical conference news, and more.
December 03, 2025
Video
Gibson discusses the promising improvements to the composite primary endpoint of mortality, stroke, and recurrent MI as a result of zalunfiban treatment.
November 09, 2025
Data from the DECAF study suggests caffeine may have a slightly beneficial effect on AF recurrence, although investigators urge caution in interpretation.
September 03, 2025
A recap 8 clinical trials in cardiovascular care to know from the European Society of Cardiology Congress 2025.
August 14, 2025
Recent research has shown long-lasting freedom of documented AF and atrial tachycardia.
August 06, 2025
July delivered 9 impactful advancements across the gamut of disciplines in cardiology.
May 05, 2025
Our April 2025 month in review highlights breakthroughs in gene therapy, device innovations, and evolving treatment strategies for cardiology.
April 30, 2025
Data suggest that etripamil may be more effective than vagal maneuvers and oral prophylaxis, minimizing emergency department visits.
April 14, 2025
Bhatt discusses his expectations for the future of cardiology in 2025, including GLP-1-RAs and the push towards combination therapy.
